Kineta's research on antiviral drugs attracts $2.8M NIH grant

08/12/2011 | American City Business Journals

The NIH's National Institute of Allergy and Infectious Disease awarded a $2.8 million grant to Kineta to develop drugs against RNA viruses, including hepatitis and flu. "Our goal is to find novel drugs that can treat infections for the long term," said Kristen Bedard, the firm's principal scientist in virology.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
PacificSource
Boise, ID